Track topics on Twitter Track topics that are important to you
GLASGOW, Scotland, October 12, 2018 /PRNewswire/ -- BDD today announced the appointment of Joanne Kelley as Non-executive Director of the Board. Jo is a Life Sciences Business Development professi...
Kelley Brodsky recognized by peers for exceptional laboratory management Proteintech, the benchmark in antibodies, today announced the winner of the 2018 Best Lab Manag...
Research focuses on Chemotherapy-Induced Peripheral Neuropathy Apexian Pharmaceuticals’ Chief Scientific Officer, Dr. Mark Kelley, has been awarded $2.3 million by the Natio...
According to Dr. Kelley, sweet cherries are low in calories, but deliver high concentrations of nutrients and bioactive components, such as fiber, polyphenols, carotenoids, vitamin Read more...
Kelley Benitez joins industry veteran Guaranteed Returns to help manage growth of onsite service in this territory. NEW YORK (PRWEB) November 13, 2018 Guaranteed Returns (GRx) is pleased to announce ...
(Indiana University) In an era of fact-checking and 'alternative facts,' many people simply choose not to believe research findings and other established facts, according to a new paper co-authored by...
National Cancer Institute Funding Brings Research Grant Budget to Nearly $700,000 Researchers will continue to explore the impact of Apexian’s target molecule, APX333...
NewsNew research from a University of Washington-led team of astronomers gives updated climate models for the seven planets around the star TRAPPIST-1.
Kelley-Seegmiller syndrome (KSS) is a disorder that occurs when there is a partial deficiency of the enzyme hypoxanthine guanine phosphoribosyl transferase. It is involved in the metabolism of purines...
Open label placebo treatment has been tried for irritable bowel syndrome (Kaptchuk et al, 2010), where three weeks of open label placebo proved superior to a wait-listed control group. Ano...
EpiCept Corporation: 777 Old Saw Mill River Road Tarrytown, NY 10591 Robert W. Cook (914) 606-3500 firstname.lastname@example.org Investors: Lippert/Heilshorn & Associates Kim Sutton Golodetz (212) 838-3777 email@example.com or Bruce Voss (310) 691-7100 firstname.lastname@example.org
We have published hundreds of Kelley Bernheim Dolinsky, LLC news stories on BioPortfolio along with dozens of Kelley Bernheim Dolinsky, LLC Clinical Trials and PubMed Articles about Kelley Bernheim Dolinsky, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kelley Bernheim Dolinsky, LLC Companies in our database. You can also find out about relevant Kelley Bernheim Dolinsky, LLC Drugs and Medications on this site too.